Pharmaceutical development company investigating cyberattack after LockBit posting

A Nasdaq-listed pharmaceutical development company said it is investigating a cybersecurity incident following claims from the LockBit ransomware gang that data was stolen.  A spokesperson for Crinetics Pharmaceuticals — a clinical stage company focused on the development and commercialization of therapeutics for endocrine diseases and endocrine-related tumors — told Recorded Future News that it

claims cyberattack cybercrime cybersecurity cybersecurity incident data development future gang incident industry lockbit lockbit ransomware nasdaq pharmaceutical pharmaceuticals ransomware ransomware gang recorded future spokesperson stage stolen